Skip to main content
Clinical Trials/NCT06899971
NCT06899971Not yet recruitingNot Applicable

The Association Between Tau & GFAP and Postoperative Neurological Impairment in Patients Undergoing Cardiac Surgery

Boston Children's Hospital1 site in 1 country100 target enrollmentStarted: May 1, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
100
Locations
1
Primary Endpoint
Characterization of postoperative neurological impairment

Study Overview

Brief Summary

Patients born with heart defects often undergo surgical procedures on a heart lung machine. With improvements in medical and surgical management, their survival has significantly improved, but their brain insult has not been paid much attention. This study is to determine the relationship between specific proteins in the blood and brain injury in patients less than 18-year-old undergoing heart surgery.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
— to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • less than 18 years old
  • undergoing cardiac surgery with cardiopulmonary bypass at Boston Children's Hospital

Exclusion Criteria

  • undergoing an emergent procedure and do not have more than 1 hour ahead of time to review the consent
  • patient in a moribund condition American Society of Anesthesiology (ASA 5)
  • patient with a hematological and/or oncological disease
  • Jehovah witnesses
  • patient on preoperative mechanical ventilation

Arms & Interventions

Cardiac Surgery Patients

Patients less than 18 years old who undergo cardiac surgical procedures on cardiopulmonary bypass.

Intervention: Collecting discarded blood samples (Other)

Outcomes

Primary Outcomes

Characterization of postoperative neurological impairment

Time Frame: 24 hours following surgery

Understand the correlation between measured proinflammatory cytokines and several proteins that are highly expressed in brain cells with postoperative neurological status.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Koichi Yuki

Principal Investigator, MD

Boston Children's Hospital

Study Sites (1)

Loading locations...

Similar Trials